An MLST approach to support tracking of plasmids carrying OXA-48-like carbapenemase
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An MLST approach to support tracking of plasmids carrying OXA-48-like carbapenemase
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-03-14
DOI
10.1093/jac/dkz136
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular epidemiology of NDM-1- and OXA-48-producing Klebsiella pneumoniae in an Iranian hospital: clonal dissemination of ST11 and ST893
- (2018) Hamid Solgi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- GrapeTree: visualization of core genomic relationships among 100,000 bacterial pathogens
- (2018) Zhemin Zhou et al. GENOME RESEARCH
- Monitoring microevolution of OXA-48-producing Klebsiella pneumoniae ST147 in a hospital setting by SMRT sequencing
- (2017) Andreas E Zautner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014
- (2017) Jacqueline Findlay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prolonged carriage and potential onward transmission of carbapenemase-producing Enterobacteriaceae in Dutch travelers
- (2016) Jarne M van Hattem et al. Future Microbiology
- Characterisation of OXA-244, a chromosomally-encoded OXA-48-like β-lactamase from Escherichia coli
- (2016) Anaïs Potron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clonal expansion of Escherichia coli ST38 carrying a chromosomally integrated OXA-48 carbapenemase gene
- (2016) Jane F. Turton et al. JOURNAL OF MEDICAL MICROBIOLOGY
- MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets
- (2016) Sudhir Kumar et al. MOLECULAR BIOLOGY AND EVOLUTION
- Nosocomial Outbreak of OXA-48-Producing Klebsiella pneumoniae in a Chinese Hospital: Clonal Transmission of ST147 and ST383
- (2016) Ling Guo et al. PLoS One
- First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing
- (2015) Yanbin Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-producingEnterobacteriaceaein Europe: assessment by national experts from 38 countries, May 2015
- (2015) Barbara Albiger et al. Eurosurveillance
- Within-Host and Population Transmission of blaOXA-48 in K. pneumoniae and E. coli
- (2015) Manon R. Haverkate et al. PLoS One
- Emergence of Escherichia coli producing OXA-48 β-lactamase in the community in Switzerland
- (2015) Katrin Zurfluh et al. Antimicrobial Resistance and Infection Control
- Differentiation of IncL and IncM Plasmids Associated with the Spread of Clinically Relevant Antimicrobial Resistance
- (2015) Alessandra Carattoli et al. PLoS One
- IS1R-Mediated Plasticity of IncL/M Plasmids Leads to the Insertion ofblaOXA-48into the Escherichia coli Chromosome
- (2014) R. Beyrouthy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Description of OXA-48 Carbapenemase Harbored by Escherichia coli and Enterobacter cloacae from a Single Patient in Portugal
- (2014) Vera Manageiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011
- (2014) M J Dautzenberg et al. Eurosurveillance
- Molecular Analysis of OXA-48-Carrying Conjugative IncL/M-Like Plasmids in Clinical Isolates of Klebsiella pneumoniae in Ireland
- (2014) Karen Power et al. Microbial Drug Resistance
- Derepressed Transfer Properties Leading to the Efficient Spread of the Plasmid Encoding Carbapenemase OXA-48
- (2013) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early (2008–2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK
- (2013) Claire P. Thomas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli
- (2013) R. Beyrouthy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints
- (2012) E.A. Reuland et al. CLINICAL MICROBIOLOGY AND INFECTION
- Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK
- (2012) V. Dimou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OXA-48-like carbapenemases: the phantom menace
- (2012) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of acquired antimicrobial resistance genes
- (2012) E. Zankari et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- First Clinical Cases of OXA-48-Producing Carbapenem-Resistant Klebsiella pneumoniae in the United States: the "Menace" Arrives in the New World
- (2012) A. J. Mathers et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain
- (2012) K. A. Jolley et al. MICROBIOLOGY-SGM
- Genetic Features of the Widespread Plasmid Coding for the Carbapenemase OXA-48
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data
- (2011) T. Carver et al. BIOINFORMATICS
- BIGSdb: Scalable analysis of bacterial genome variation at the population level
- (2011) Keith A Jolley et al. BMC BIOINFORMATICS
- Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae
- (2011) R.L. Swayne et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
- (2010) A. Carrer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now